YI Company Profile and Key Details

Q: Who are the executives of YI?

Mr. Junling LiuCo-Founder, Acting Chief Financial Officer, Chairman & Chief Executive OfficerMr. Pengcheng ZhuCo-Chief Operating OfficerMonica MuIR DirectorMr. Haihui WangCo-Chief Operating OfficerMr. Alex LiuFin. DirectorDr. Gang YuCo-Founder & Executive ChairmanMr. Anfeng GuoChief Innovation Officer

NASDAQ : YI

111

$6.60

-0.1268-1.89%

At Close 4:00 PM

61.11

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

111, Inc. (YI) stock declined over -1.89%, trading at $6.60 on NASDAQ, down from the previous close of $6.73. The stock opened at $6.70, fluctuating between $6.51 and $7.10 in the recent session.

Stock Snapshot

6.7268

Prev. Close

57.21M

Market Cap

6.51

Day Low

-0.3

P/E Ratio

-22.29

EPS (TTM)

-3.6

Cash Flow per Share

6.7

Open

8.67M

Number of Shares

7.1

Day High

98.18%

Free Float in %

-6.87

Book Value

54.73K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 20, 2026	6.60	7.10	6.51	6.60	54.77K
Apr 17, 2026	6.72	6.81	6.66	6.73	12.77K
Apr 16, 2026	6.90	7.03	6.63	6.67	21.88K
Apr 14, 2026	6.67	7.03	6.61	6.81	2.96K
Apr 13, 2026	6.95	7.25	6.79	6.79	10.45K
Apr 10, 2026	6.49	6.87	6.36	6.58	6.25K
Apr 09, 2026	6.53	6.55	6.31	6.41	13.11K
Apr 08, 2026	6.41	6.63	6.41	6.48	5.93K
Apr 07, 2026	6.43	6.43	6.20	6.22	2.17K
Apr 06, 2026	6.64	6.64	6.43	6.52	3.3K
Apr 02, 2026	6.91	7.13	6.44	6.44	6.53K
Apr 01, 2026	6.50	7.19	6.50	6.62	15.89K
Mar 31, 2026	6.30	6.65	6.28	6.52	8.32K
Mar 30, 2026	6.27	6.43	6.27	6.43	5.04K
Mar 27, 2026	6.40	6.40	6.11	6.24	10.7K
Mar 25, 2026	6.07	7.19	6.07	6.29	22.75K
Mar 24, 2026	6.65	6.81	6.15	6.36	45.78K
Mar 23, 2026	6.71	6.81	6.41	6.70	12.43K
Mar 20, 2026	6.95	6.99	6.45	6.85	21.42K
Mar 19, 2026	6.63	6.63	6.26	6.59	8.44K

Contact Details

Shanghai, 201203

China

https://www.111.com.cn 862 120 536666

About Company

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Stock Peers

ONC

-5.8-1.79%

BeOne Medicines Ltd.$318.07 HROWM

-0.02-0.08%

Harrow Health, Inc. 11.875% Senior Notes due 2027$26.03 HROWL

0.0478+0.19%

Harrow Health, Inc. 8.625% Senior Notes due 2026$25.61 LFMDP

-0.07-0.29%

LifeMD, Inc.$23.85 CGEM

-0.54-3.59%

Cullinan Therapeutics, Inc.$14.52 WBA

0.06+0.50%

Walgreens Boots Alliance, Inc.$11.98 MSLE

-0.87-10.00%

Satellos Bioscience Inc. Common Stock$7.83 MEDS

0.33+4.55%

TRxADE HEALTH, Inc.$7.59 KYNB

0.02+0.27%

Kyntra Bio, Inc.$7.34 POZN

-0.41-6.90%

POZEN Inc.$5.94

Company Overview

111, Inc. (NASDAQ:YI) closed at $6.60 USD, losing -$0.13 (-1.88%) from the previous close of $6.73. The stock is currently mid-range between its 52-week high and low $2.48 and $11.17. With a market capitalization of about $57.21 million, 111, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.70). Key stats such as the average daily volume over the past year has been around 29.46 thousand shares, trading with heavier-than-usual volume. Headquartered in Shanghai, None, 111, Inc. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Junling Liu, the company employs approximately 1,238 people and listed since September 12, 2018. 111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China.

Technical Performance

YI has shown sold momentum, gaining 39.18% over the past week and 19.25% over the past quarter, though year-to-date performance is up 98.44%. Short-term trend indicators are mixed aligned (SMA20 4.8%, SMA50 48.61%, SMA200 37.04%). The stock’s 14-day RSI is 67.11 (firm momentum), while the ATR of 0.58 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -28.78% below its high and over 225.81% above its low. Average 10-day trading volume of 20.56 thousand shares is below the 3-month average of 30.23 thousand, indicating normal recent market interest.

Valuation Metrics

111, Inc. trades at a P/E ratio of -7.03, slightly below the S&P 500 average, with a price-to-sales ratio of 0.03 and a price-to-book ratio of -0.56 indicating negative book value, which may reflect financial stress. The P/FCF stands at -31.05, also below market averages.

Dividend & Fair Value

111, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $10.91. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

111, Inc. generated EPS of -$1.12 over the past year. Five-year average earnings growth is 34.73%.

Shareholding & Insider Activity

111, Inc. has 5.07 million shares outstanding. The public float is 70.01 million shares, elevated short interest at 0.02% of float. This equals 904.00 shares. The short ratio is 0.07 days. Institutional investors hold 1.37% of the float. Insiders own 8.58%.

Financial & Profitability Overview

Over the trailing twelve months, 111 generated $14.95B in revenue, or $177.31 per share. Gross margin was 3.00%, operating margin -2.34%, and net profit margin -2.63%. Returns are negative, with ROA at -11.30% and ROE at 94.72%.
On valuation metrics, 111 trades at a P/E of -7.03, P/S of 0.03 and P/B of -0.56. The current ratio is 1.09 and quick ratio is 0.58. Operationally, the company’s inventory turnover is 11.81 and cash conversion cycle is 0.50 days. Debt-to-equity is -0.31, supported by a cash flow-to-debt ratio of 0.01.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, 111 posted revenue of $14.95B, down slightly from $13.52B in the prior quarter. Gross profit was $448.44M (margin 3.00%). Operating income was - $350.10M (margin -2.3%). Net income was- $392.69M (EPS - $4.66).
The company ended the quarter with $879.53M in cash and short-term investments, a total debt of $279.46M, and net debt of - $394.21M. Total assets were $3.47B, with equity of $648.24M. Financials further reflected weakness, with operating cash flow of - $23.15M, free cash flow of - $54.73M, and capital expenditures of - $31.57M.

Price Forecast & Outlook

Our AI price prediction model suggests that 111, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 3.79%, with price expected at $6.85 by May 04, 2026, within a range of $6.57 to $7.13 3-Month Outlook: Projected rise of 155.61%, reaching $16.87 by July 16, 2026, with a range of $16.49 to $17.55. 1-Year Outlook: Projected gain of 121.21%, with price at $14.60 by April 20, 2027, within a range of $3.86 to $16.44.

Key Takeaways

111, Inc. (NASDAQ:YI) shares are up 98.44% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows 111, Inc. trading at a premium to the broader market with a P/E of -7.03. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $16.00, suggesting 142.42% upside. Our AI forecast model points to short-term strength (3.79% over two weeks), a medium-term rise (155.61% over three months), and a longer-term gain (121.21% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current 111, Inc. (YI) stock price?

111, Inc. (NASDAQ: YI) stock price is $6.60 in the last trading session. During the trading session, YI stock reached the peak price of $7.10 while $6.51 was the lowest point it dropped to. The percentage change in YI stock occurred in the recent session was -1.89% while the dollar amount for the price change in YI stock was - $0.13.

YI's industry and sector of operation?

The NASDAQ listed YI is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector. 111, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of YI?

Mr. Junling Liu
Co-Founder, Acting Chief Financial Officer, Chairman & Chief Executive Officer
Mr. Pengcheng Zhu
Co-Chief Operating Officer
Monica Mu
IR Director
Mr. Haihui Wang
Co-Chief Operating Officer
Mr. Alex Liu
Fin. Director
Dr. Gang Yu
Co-Founder & Executive Chairman
Mr. Anfeng Guo
Chief Innovation Officer

How YI did perform over past 52-week?

YI's closing price is 166.13% higher than its 52-week low of $2.48 where as its distance from 52-week high of $11.17 is -40.91%.

How many employees does YI have?

Number of YI employees currently stands at 1,238.

Link for YI official website?

Official Website of YI is: https://www.111.com.cn

How do I contact YI?

YI could be contacted at phone 862 120 536666 and can also be accessed through its website. YI operates from No.295 ZuChongZhi Road, Shanghai, 201203, China.

How many shares of YI are traded daily?

YI stock volume for the day was 54.73K shares. The average number of YI shares traded daily for last 3 months was 29.46K.

What is the market cap of YI currently?

The market value of YI currently stands at $57.21M with its latest stock price at $6.60 and 8.67M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1238
Beta	0.64
Sales or Revenue	$14.95B
5Y Sales Change%	3.937%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Pharmaceuticals

YI Company Profile and Key Details

111

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Company Overview

Price Forecast & Outlook

Key Takeaways